| Application no. and date | 99962471.1 (espacenet) (Federated) (European Patent Register), 19991223 | | Patent/reg. no. and date | DK/EP 1144389, 20041110 | | Publication date | 20011017 | | Priority no. and date | GB 9900339, 19990109 | | EP pub. no. and date |
EP 1144389 20011017 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | TAYLOR, Nigel, Phillip, Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/505, A61P 3/06, C07D 239/42 | | Title | Krystallinsk bis(E)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-ensyre]calciumsalt | | Int. application no. | GB1999004439 | | Int. publication no. | WO2000042024 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
